A Phase II Study of 9MW3811 in Patients With Pathological Scar
Clinical trial NCT07576608 · RECRUITING
Trial details
- NCT number
- NCT07576608
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-29
- Primary completion
- 2026-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.